Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
K Murakami-Mori, … , T Kishimoto, S Nakamura
K Murakami-Mori, … , T Kishimoto, S Nakamura
Published September 1, 1995
Citation Information: J Clin Invest. 1995;96(3):1319-1327. https://doi.org/10.1172/JCI118167.
View: Text | PDF
Research Article Article has an altmetric score of 3

AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.

  • Text
  • PDF
Abstract

Oncostatin M (OM), which shares functional similarity and structural homology to leukemia inhibitory factor (LIF) and interleukin-6 (IL-6), functions as a potent growth factor for AIDS-associated Kaposi's sarcoma-derived cells (AIDS-KS cells). OM was also suggested to bind to the LIF receptor (LIF/OM receptor), which consists of a signal transducing subunit for LIF and IL-6 (gp130) and a LIF receptor alpha-subunit. Recent studies indicate that IL-6 has growth-stimulating activity for AIDS-KS cells. However, we find that AIDS-KS cell growth is exclusively induced by OM and not by LIF or IL-6. We also observed the lack of binding properties of AIDS-KS cells for LIF and IL-6. Scatchard plots revealed the existence of two affinity classes of OM receptor sites on AIDS-KS cells, with Kd values of 6-12 pM (high affinity) and 521-815 pM (low affinity). In competition binding studies, we find that the OM-specific receptor, but not the LIF/OM receptor, contributes to the OM-specific growth stimulation of AIDS-KS cells. We also noted that anti-gp130 antibodies can completely abolish OM-induced growth stimulation of AIDS-KS cells as well as OM binding to AIDS-KS cells. PCR amplification clearly revealed high levels of gp130 expression in AIDS-KS cells, while the transcript of LIF receptor alpha-subunit or IL-6 receptor alpha-subunit was not observed. Therefore, we conclude that (a) AIDS-KS cells express the OM-specific receptor with high and low affinity, but not the LIF/OM receptor; (b) gp130 on AIDS-KS cells plays a key role in OM binding and signaling on the OM-specific receptor; and (c) the lack of biological response of AIDS-KS cells to IL-6 and LIF can be explained by the absence of the IL-6 and LIF/OM receptors. All this evidence shows the correlation of OM-specific biological activity with expression of the OM-specific receptor and the involvement of gp130 on this receptor, as based on findings in in vitro growth assays and binding experiments for AIDS-KS cells.

Authors

K Murakami-Mori, T Taga, T Kishimoto, S Nakamura

×

Total citations by year

Year: 2023 2022 2012 2011 2010 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1990 Total
Citations: 1 1 1 3 1 1 2 1 2 2 2 2 3 4 11 2 1 40
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (40)

Title and authors Publication Year
The clinical relevance of OSM in inflammatory diseases: a comprehensive review
Wolf CL, Pruett C, Lighter D, Jorcyk CL
Frontiers in immunology 2023
The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights.
Halder S, Parte S, Kshirsagar P, Muniyan S, Nair HB, Batra SK, Seshacharyulu P
2022
Effect of formaldehyde at a low concentration on proliferation and organization of cytoskeleton of cultured cells
AA Aizenshtadt, EB Burova, VV Zenin, DE Bobkov, IV Kropacheva, GP Pinaev
Cell and Tissue Biology 2012
Kaposi's Sarcoma-Associated Herpesvirus Infection of Endothelial Cells Inhibits Neutrophil Recruitment through an Interleukin-6-Dependent Mechanism: a New Paradigm for Viral Immune Evasion
LM Butler, HC Jeffery, RL Wheat, PC Rae, K Townsend, KR Alkharsah, TF Schulz, GB Nash, DJ Blackbourn
Journal of virology 2011
Blocking MAPK Signaling Downregulates CCL21 in Lymphatic Endothelial Cells and Impairs Contact Hypersensitivity Responses
T Miyagaki, M Sugaya, H Okochi, Y Asano, Y Tada, T Kadono, A Blauvelt, K Tamaki, S Sato
Journal of Investigative Dermatology 2011
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken
Advances in Cancer Research Volume 110 2011
Topley & Wilson's Microbiology and Microbial Infections
PM Pitha, MS Künzi
Topley & Wilson's Microbiology and Microbial Infections 2010
Oncostatin M Enhances CCL21 Expression by Microvascular Endothelial Cells and Increases the Efficiency of Dendritic Cell Trafficking to Lymph Nodes
M Sugaya, L Fang, AR Cardones, T Kakinuma, SH Jaber, A Blauvelt, ST Hwang
Journal of immunology (Baltimore, Md. : 1950) 2006
Transcriptional responses of human epidermal keratinocytes to Oncostatin-M
N Finelt, A Gazel, S Gorelick, M Blumenberg
Cytokine 2005
Cross-talk among gp130 Cytokines in Adipocytes
S Zvonic, JE Baugh, P Arbour-Reily, RL Mynatt, JM Stephens
The Journal of biological chemistry 2005
Therapeutic options for human herpesvirus-8/Kaposi’s sarcoma-associated herpesvirus-related disorders
Y Aoki, G Tosato
Expert Review of Anti-infective Therapy 2004
Pathogenesis and manifestations of human herpesvirus-8-associated disorders
Y Aoki, G Tosato
Seminars in Hematology 2003
Targeted disruption of oncostatin M receptor results in altered hematopoiesis
M Tanaka, Y Hirabayashi, T Sekiguchi, T Inoue, M Katsuki, A Miyajima
Blood 2003
The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases
Karl-Josef Kallen
Biochimica et Biophysica Acta 2002
Structure-Function Relationships of Human Pathogenic Viruses
A Holzenburg, E Bogner
2002
Exclusive neutrophil recruitment with oncostatin M in a human system
SM Kerfoot, E Raharjo, M Ho, J Kaur, S Serirom, DM McCafferty, AR Burns, KD Patel, P Kubes
The American Journal of Pathology 2001
Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells
A Kasza, K Rogowski, W Kilarski, R Sobota, T Bernas, J Dobrucki, J Travis, A Koj, M Bugno, T Kordula
Biochemical Journal 2001
State-of-the-Art Review: Kaposi's Sarcoma-Associated Herpesvirus-Encoded Interleukin-6
Y Aoki, KD Jones, G Tosato
Journal of Hematotherapy & Stem Cell Research 2000
Oncostatin M and Transforming Growth Factor-β1 Induce Post-translational Modification and Hyaluronan Binding to CD44 in Lung-derived Epithelial Tumor Cells
J Cichy, E Puré
The Journal of biological chemistry 2000
p38MAP Kinase Is a Negative Regulator for ERK1/2-Mediated Growth of AIDS-Associated Kaposi's Sarcoma Cells
K Murakami-Mori, S Mori, S Nakamura
Biochemical and Biophysical Research Communications 1999
The role of HHV-8 in Kaposi's sarcoma
F Neipel, B Fleckenstein
Seminars in Cancer Biology 1999
HIV and the New Viruses
S McAdam, F Gotch
HIV and the New Viruses 1999
Advances in Protein Chemistry
CM Silva, J Isgaard, MO Thorner
Advances in Protein Chemistry 1998
Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex
GE Ringheim, AM Szczepanik, W Petko, KL Burgher, SZ Zhu, CC Chao
Molecular Brain Research 1998
Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents
B Ensoli
Cytokine & Growth Factor Reviews 1998
Oncostatin M and the Interleukin-6 and Soluble Interleukin-6 Receptor Complex Regulate α 1 -Antichymotrypsin Expression in Human Cortical Astrocytes
T Kordula, RE Rydel, EF Brigham, F Horn, PC Heinrich, J Travis
The Journal of biological chemistry 1998
Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow
SC Lin, T Yamate, Y Taguchi, VZ Borba, G Girasole, CA O'Brien, T Bellido, E Abe, SC Manolagas
Journal of Clinical Investigation 1997
Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6
J Nicholas, VR Ruvolo, WH Burns, G Sandford, X Wan, D Ciufo, SB Hendrickson, HG Guo, GS Hayward, MS Reixz
Nature Medicine 1997
The therapeutic potential of interleukin-6 hyperagonists and antagonists
KJ Kallen, KH Büschenfelde, S Rose-John
Expert Opinion on Investigational Drugs 1997
Cytokines and the hepatic acute phase response
H Moshage
The Journal of Pathology 1997
The Signal Transducer gp130 Is Shared by lnterleukin-6 Family of Haematopoietic and Neurotrophic Cytokines
T Taga
Annals of Medicine 1997
gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
T Taga, T Kishimoto
Annual Review of Immunology 1997
Human herpesvirus 8 encodes a homolog of interleukin-6
F Neipel, JC Albrecht, A Ensser, YQ Huang, JJ Li, AE Friedman-Kien, B Fleckenstein
Journal of virology 1997
Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity?
F Neipel, JC Albrecht, B Fleckenstein
Journal of virology 1997
Isolation and Characterization of the Human gp130 Promoter: REGULATION BY STATS
CA OBrien, SC Manolagas
The Journal of biological chemistry 1997
Interleukin-4 Receptor Expression on AIDS-Associated Kaposi’s Sarcoma Cells and Their Targeting by a Chimeric Protein Comprised of Circularly Permuted Interleukin-4 and Pseudomonas Exotoxin
SR Husain, P Gill, RJ Kreitman, I Pastan, RK Puri
Molecular Medicine 1997
Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology
ES Wijelath, B Carlsen, T Cole, J Chen, S Kothari, WP Hammond
Journal of cell science 1997
Dual Oncostatin M (OSM) Receptors: CLONING AND CHARACTERIZATION OF AN ALTERNATIVE SIGNALING SUBUNIT CONFERRING OSM-SPECIFIC RECEPTOR ACTIVATION
B Mosley, CD Imus, D Friend, N Boiani, B Thoma, LS Park, D Cosman
The Journal of biological chemistry 1996
Contradictory concepts in the etiology and regression of kaposi’s sarcoma: The Ferenc Györkey memorial lecture
JG Sinkovics
Pathology & Oncology Research 1996
Bone Marrow Transplantation
R Champlin
Bone Marrow Transplantation 1990

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 Wikipedia pages
11 readers on Mendeley
See more details